Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.

Soumyajit RoyChristopher J D WallisScott C MorganAmar U KishanAmy Tu Trinh LeJulia MaloneYilun SunDaniel E SprattFred SaadShawn Malone

Published in: The Prostate (2023)

M-stage at presentation had no association with survival in chemotherapy-naïve mCRPC. We did not find any statistically significant heterogeneity in efficacy of dual ARAT based on synchronous versus metachronous presentation.

Keyphrases

prostate cancer
squamous cell carcinoma
small cell lung cancer
case report
locally advanced
single cell
radiation therapy